BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33594807)

  • 1. Droplet digital PCR of tumor suppressor gene methylation in serial oral rinses of patients with head and neck squamous cell carcinoma.
    Fung SYH; Chan KCA; Wong EWY; Ng CWK; Cho R; Yeung ZWC; Lam JWK; Chan JYK
    Head Neck; 2021 Jun; 43(6):1812-1822. PubMed ID: 33594807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses.
    Demokan S; Chang X; Chuang A; Mydlarz WK; Kaur J; Huang P; Khan Z; Khan T; Ostrow KL; Brait M; Hoque MO; Liegeois NJ; Sidransky D; Koch W; Califano JA
    Int J Cancer; 2010 Nov; 127(10):2351-9. PubMed ID: 20162572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of DNA methylation levels of
    Grossi I; Assoni C; Lorini L; Smussi D; Gurizzan C; Grisanti S; Paderno A; Mattavelli D; Piazza C; Pelisenco IA; De Petro G; Salvi A; Bossi P
    Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38299234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
    Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
    Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC.
    Sun W; Zaboli D; Liu Y; Arnaoutakis D; Khan T; Wang H; Koch W; Khan Z; Califano JA
    PLoS One; 2012; 7(3):e33642. PubMed ID: 22438973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance.
    Carvalho AL; Henrique R; Jeronimo C; Nayak CS; Reddy AN; Hoque MO; Chang S; Brait M; Jiang WW; Kim MM; Claybourne Q; Goldenberg D; Khan Z; Khan T; Westra WH; Sidransky D; Koch W; Califano JA
    Clin Cancer Res; 2011 Jul; 17(14):4782-9. PubMed ID: 21628494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
    Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
    Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paired box 5 methylation detection by droplet digital PCR for ultra-sensitive deep surgical margins analysis of head and neck squamous cell carcinoma.
    Hayashi M; Guerrero-Preston R; Sidransky D; Koch WM
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1017-26. PubMed ID: 26304463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
    van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
    BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the methylation profile of exfoliated cell samples from patients with head and neck squamous cell carcinoma.
    Longo AL; Rettori MM; de Carvalho AC; Kowalski LP; Carvalho AL; Vettore AL
    Head Neck; 2014 May; 36(5):631-7. PubMed ID: 23595968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
    Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA
    Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions.
    Schussel J; Zhou XC; Zhang Z; Pattani K; Bermudez F; Jean-Charles G; McCaffrey T; Padhya T; Phelan J; Spivakovsky S; Brait M; Li R; Bowne HY; Goldberg JD; Rolnitzky L; Robbins M; Kerr AR; Sirois D; Califano JA
    Clin Cancer Res; 2013 Jun; 19(12):3268-75. PubMed ID: 23637120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.
    Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M
    Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients.
    Rettori MM; de Carvalho AC; Bomfim Longo AL; de Oliveira CZ; Kowalski LP; Carvalho AL; Vettore AL
    Carcinogenesis; 2013 Jan; 34(1):20-7. PubMed ID: 23042095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.
    Guerrero-Preston R; Michailidi C; Marchionni L; Pickering CR; Frederick MJ; Myers JN; Yegnasubramanian S; Hadar T; Noordhuis MG; Zizkova V; Fertig E; Agrawal N; Westra W; Koch W; Califano J; Velculescu VE; Sidransky D
    Epigenetics; 2014 Jul; 9(7):1031-46. PubMed ID: 24786473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.
    Misawa K; Misawa Y; Kanazawa T; Mochizuki D; Imai A; Endo S; Carey TE; Mineta H
    Clin Exp Metastasis; 2016 Feb; 33(2):187-95. PubMed ID: 26572146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation.
    Misawa K; Mima M; Satoshi Y; Imai A; Mochizuki D; Ishikawa R; Kita J; Yamaguchi Y; Endo S; Misawa Y; Mineta H
    J Transl Med; 2020 Jan; 18(1):31. PubMed ID: 31969157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation in tumour and normal mucosal tissue of head and neck squamous cell carcinoma (HNSCC) patients: new diagnostic approaches and treatment.
    Laytragoon-Lewin N; Rutqvist LE; Lewin F
    Med Oncol; 2013; 30(3):654. PubMed ID: 23824644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma.
    Steinmann K; Sandner A; Schagdarsurengin U; Dammann RH
    Oncol Rep; 2009 Dec; 22(6):1519-26. PubMed ID: 19885608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index.
    Langevin SM; Stone RA; Bunker CH; Grandis JR; Sobol RW; Taioli E
    Carcinogenesis; 2010 May; 31(5):864-70. PubMed ID: 20197299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.